RE FRANCESCA

Amenta, A., Comi, S., Kravicz, M., Sesana, S., Antoniou, A., Passarella, D., et al. (2025). A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted cancer therapy. RSC MEDICINAL CHEMISTRY, 16(1), 168-178 [10.1039/d4md00517a]. Dettaglio

Sierri, G., Saenz-De-Santa-Maria, I., Renda, A., Koch, M., Sommi, P., Anselmi-Tamburini, U., et al. (2025). Nanoparticle shape is the game-changer for blood-brain barrier crossing and delivery through tunneling nanotubes among glioblastoma cells. NANOSCALE, 17(2), 992-1006 [10.1039/d4nr03174a]. Dettaglio

Viale, F., Ciprandi, M., Leoni, L., Sierri, G., Renda, A., Barbugian, F., et al. (2024). Biodegradable SPI-based hydrogel for controlled release of nanomedicines: a potential approach against brain tumors recurrence. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 96(June 2024) [10.1016/j.jddst.2024.105672]. Dettaglio

Resnik, N., Levallet, G., Errede, M., Re, F., Virgintino, D. (2024). Editorial: Molecular profiles of tunneling nanotubes (TNTs) in human diseases-from 2D cultures to complex tissue. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 14(12) [10.3389/fcell.2024.1461453]. Dettaglio

Kravicz, M., Taiarol, L., Viegas, J., Sierri, G., Mauri, M., Koch, M., et al. (2024). Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 101(Part A November 2024) [10.1016/j.jddst.2024.106238]. Dettaglio